Skip to main content

Year: 2023

Company Announcement 5/2023

NOTICE TO CONVENE an extraordinary general meeting of Nordic Shipholding A/S in liquidation Nordic Shipholding A/S in liquidation (CVR no. 76 35 17 16) (the “Company”) hereby convenes an extraordinary general meeting to be held on Thursday 28 December 2023, at 09.00 (CET) Gorrissen Federspiel, Axel Towers, Axeltorv 2, DK-1609 Copenhagen V Agenda: 1.   Presentation of the liquidator’s report 2.   Presentation of the final and audited liquidation accounts for adoption 3.   Resolution on liquidation of the Company with final effect 4.   Any other business Complete proposalsItem 1 – Presentation of the liquidator’s reportItem 2 – Presentation of the final and audited liquidation accounts for adoption The liquidator proposes to the general meeting to adopt the final and audited liquidation accounts. There will be no distribution of liquidation...

Continue reading

Navitas Ranked Top 50 in Forbes’ 2024 Most Successful Small Companies

Ranking recognizes growth driven by strong demand for next-gen GaN and SiC power semis in EV, solar, appliance / industrial, data center and mobileNavitas Ranked Top 50 in Forbes’ 2024 Most Successful Small CompaniesRanking recognizes growth driven by strong demand for next-gen GaN and SiC power semis in EV, solar, appliance / industrial, data center and mobileTORRANCE, Calif., Dec. 06, 2023 (GLOBE NEWSWIRE) — Navitas Semiconductor (Nasdaq: NVTS), the pure-play industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC) power semiconductors, secured the 49th position on Forbes’ 2024 America’s Successful Small Companies list. The ranking is recognition of the company’s growth based on strong demand for Navitas’ advanced, high-efficiency, wide bandgap (WBG)...

Continue reading

Alto Ingredients, Inc. Extends Term Loan Commitment Period

PEKIN, Ill., Dec. 06, 2023 (GLOBE NEWSWIRE) — Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols and essential ingredients, announced that it has amended its $125 million senior secured term loan facility with certain funds managed by Orion Infrastructure Capital (“OIC”) to extend the commitment period for undrawn capital available under the term loan facility by one year to November 2024. No other material terms were changed. Alto Ingredients’ CFO, Rob Olander, said, “This extension of our commitment period by one year provides Alto additional liquidity and optionality as we continue to evaluate and fund our capital projects. This extension also shows the level of cooperation we have had with OIC, and we believe their support demonstrates confidence in our strategy.” About Alto Ingredients,...

Continue reading

Lead Real Estate Co., Ltd Announces Sale of 17-unit Luxury Condominium in Tokyo

Tokyo, Dec. 06, 2023 (GLOBE NEWSWIRE) — Lead Real Estate Co., Ltd (Nasdaq: LRE) (the “Company”), a Japanese real estate developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo, today announced that, on November 28, 2023, it completed the sale and delivery of a newly built single luxury income-producing condominium. The 17-unit property, Excelsior Meguromita, located in Meguro, Tokyo, is made from reinforced concrete and has four floors above ground and one basement floor. It has a building area of 10,232 square feet and land area of 3,810 square feet. Due to a confidentiality agreement with the seller, the seller and the sale price are not disclosed. There are no capital, personal, or business relationships between the Company and the seller, and...

Continue reading

Clarus Reports Status of HAP Trading Short-Swing Profit Litigation

SALT LAKE CITY, Dec. 06, 2023 (GLOBE NEWSWIRE) — Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor and consumer enthusiast markets, reported on the status of its claims against HAP Trading, LLC and Mr. Harsh A. Padia (collectively “HAP Trading”). On November 20, 2023, Clarus submitted its expert’s report calculating the recovery that may be available to Clarus from HAP Trading’s purchases and sales of Clarus common stock in violation of Section 16(b) of the Securities Exchange Act of 1934, as amended. Clarus engaged Charles Lundelius, a Managing Director with Berkeley Research Group, LLC (“BRG”) (https://www.thinkbrg.com/people/charles-lundelius/) to conduct a comprehensive review of HAP Trading’s transactions in shares of Clarus’ common stock during the period July 19, 2022...

Continue reading

Verizon Business and Zebra Technologies launch device and software solutions to accelerate private 5G

What you need to know:Zebra mobile device and software packaged solutions are certified to work with Verizon Private 5G and LTE networks throughout the U.S., helping private-network customers get operations up and running faster Zebra solutions can enable frontline workers in multiple industries to manage projects and communications on jobsites more efficiently, getting the most out of private 5G and LTE in diverse commercial environments from retail to heavy industry Select devices have multi-SIM capability for near-seamless transitions between an authenticated private network and Verizon’s public networkBASKING RIDGE, N.J. and LINCOLNSHIRE, Ill., Dec. 06, 2023 (GLOBE NEWSWIRE) — Verizon Business (NYSE, Nasdaq: VZ) and Zebra Technologies (NASDAQ: ZBRA), a leader in digital solutions that accelerate business workflows, today...

Continue reading

Webuy Global Announces MOU to Acquire PT. Tiga Sakti Utama (TSU), a Leading Indonesian Fruit Importer and Wholesaler in Surabaya, Indonesia

Strategic acquisition intended to expand the company’s foothold in Indonesia and SE Asia TSU generated sales of approximately $15 million in 2022 with track record of profitability Singapore , Dec. 06, 2023 (GLOBE NEWSWIRE) — Webuy Global Ltd (Nasdaq: WBUY) (“Webuy” or the “Company”), an emerging community e-commerce retailer with a focus on grocery and travel in Southeast Asia, today announced it has entered into a non-binding Memorandum of Understanding (“MOU”) to acquire controlling interest in PT. Tiga Sakti Utama (“TSU”), a leading importer and wholesaler of fruits in Surabaya, Indonesia.  Under the MOU, the Company would receive a 51% equity interest in TSU in exchange for 800,000 of the Company’s ordinary shares with certain lockup arrangement.  Pending the execution of a definitive agreement between the parties, the acquisition...

Continue reading

Global Telehealth Market Size, Share & Growth Analysis, [2030] | With CAGR of 19.7%

As per the report by Fortune Business Insights, The global telehealth market size was valued at USD 128.12 billion in 2022. The market is projected to grow from USD 142.96 billion in 2023 to USD 504.24 billion by 2030 at a CAGR of 19.7% during the forecast period.Telehealth MarketForecast 2023-2030Pune, India, Dec. 06, 2023 (GLOBE NEWSWIRE) — Global telehealth market size was valued at USD 128.12 billion in 2022 The market is projected to grow from USD 504.24 billion by 2030 at a CAGR of 19.7% during the forecast period.The increasing adoption of telehealth is growing dramatically, especially in behavioral health, radiology, cardiology, and online consultation. The market is getting a significant boom with the growing start-up’s launch and funding of products, especially for virtual consultations. This information...

Continue reading

Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea

On track to submit a New Drug Application to the FDA for DFD-29 around year-end of 2023 SCOTTSDALE, Ariz., Dec. 06, 2023 (GLOBE NEWSWIRE) — Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that the Company received the official meeting minutes from its pre-New Drug Application (“NDA”) meeting with the FDA for DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) to treat rosacea in adults. DFD-29 is being developed in collaboration with Dr. Reddy’s Laboratories Ltd. The purpose of the meeting was to discuss the 505(b)(2) NDA submission plan...

Continue reading

Automate Installation Process with Press-Fit Terminal Power Modules for a Solder-Free Solution in High-Volume Manufacturing

Microchip’s SP1F and SP3F power modules are highly configurable in Silicon Carbide (SiC) or Silicon (Si) technology and now available with Press-Fit terminals CHANDLER, Ariz., Dec. 06, 2023 (GLOBE NEWSWIRE) — The E-Mobility, sustainability and data center markets require products that are conducive to high-volume manufacturing. To better automate the installation process, Press-Fit terminals are often used because they offer a solder-free solution to mount power modules to the PCB. Microchip Technology (Nasdaq: MCHP) today announces its expansive portfolio of SP1F and SP3F power modules are now available with Press-Fit terminals for high-volume applications. Solder-free Press-Fit power module terminals allow for automated or robotic installation, which simplifies and speeds up the assembly process to reduce manufacturing costs....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.